Accsys Technologies (AXS) H2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2026 earnings summary
16 Jun, 2026Executive summary
Achieved record global Accoya sales volumes, up 21% year-over-year, with strong growth in all key regions, especially North America.
Group revenue increased 20% on a like-for-like basis, reflecting resilient demand, pricing discipline, and commercial platform strength.
Adjusted EBITDA rose 96% to EUR 21.2 million, with margin improving to 11.6%, nearing the Phase I FOCUS target.
Accoya USA JV delivered a 178% increase in Accsys' share of revenues, turned EBITDA positive, and achieved 60% volume growth.
Leverage ratio reduced to 1.96x, supported by refinancing on improved terms, strengthening capital structure and financial flexibility.
Financial highlights
Group revenue reached EUR 153 million, up 20% like-for-like; aggregated revenue (including JV) up 24% to EUR 183 million.
Adjusted EBITDA rose to EUR 21.2 million (11.6% margin), up from EUR 10.8 million (7.3% margin) in FY25.
Underlying basic EPS improved to EUR 0.021 from a loss of EUR 0.05 in the prior year.
Operating cash flow conversion increased to 75%; free cash flow EUR 10.3 million.
Net debt reduced to EUR 41.4 million; leverage ratio improved to 1.96x.
Outlook and guidance
On track to deliver Phase I FY27 FOCUS targets, including 100,000m³ sales volume and 12% adjusted EBITDA margin.
Trading in line with board expectations for FY 2027; focus on innovation, market share gains, profitability, and leveraging existing team.
Expect continued double-digit growth in Accoya Color and further expansion in North America.
Gross margin expected to remain above 30.9% in FY 2027, though not likely to repeat the 130 bps leap.
Macroeconomic uncertainty persists, but product differentiation and pricing discipline position the group well.
Latest events from Accsys Technologies
- Record sales and 20% revenue growth driven by strong North America performance.AXS
Trading update21 Apr 2026 - Cost savings, new US capacity, and equity raise drive growth despite revenue decline.AXS
H2 20243 Feb 2026 - 160% EBITDA rise, 22% sales growth, and robust North American momentum drive strong H1.AXS
H1 202614 Jan 2026 - Adjusted EBITDA up 125% and sales volumes up 13%, driven by US expansion and efficiency gains.AXS
H2 202514 Jan 2026 - Double-digit sales growth, margin gains, and US JV ramp-up drive upgraded outlook.AXS
H1 202512 Jan 2026 - Kingsport plant launch and Q1 growth signal Accsys's strong momentum and expansion.AXS
Trading Update13 Jun 2025 - FY25 revenue and sales volumes rose strongly as Accsys advanced its FOCUS strategy.AXS
Trading Update6 Jun 2025 - Phased strategy targets rapid volume growth, margin expansion, and sustainable innovation.AXS
CMD 20256 Jun 2025